Suppr超能文献

全球 MYH9 肾脏疾病易感等位基因和单倍型的分布:非洲历史选择的证据。

Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.

机构信息

Department of Biology, University of Puerto Rico at Mayagüez, Mayagüez, Puerto Rico.

出版信息

PLoS One. 2010 Jul 9;5(7):e11474. doi: 10.1371/journal.pone.0011474.

Abstract

MYH9 was recently identified as renal susceptibility gene (OR 3-8, p < 10(-8)) for major forms of kidney disease disproportionately affecting individuals of African descent. The risk haplotype (E-1) occurs at much higher frequencies in African Americans (> or = 60%) than in European Americans (< 4%), revealing a genetic basis for a major health disparity. The population distributions of MYH9 risk alleles and the E-1 risk haplotype and the demographic and selective forces acting on the MYH9 region are not well explored. We reconstructed MYH9 haplotypes from 4 tagging single nucleotide polymorphisms (SNPs) spanning introns 12-23 using available data from HapMap Phase II, and by genotyping 938 DNAs from the Human Genome Diversity Panel (HGDP). The E-1 risk haplotype followed a cline, being most frequent within sub-Saharan African populations (range 50-80%), less frequent in populations from the Middle East (9-27%) and Europe (0-9%), and rare or absent in Asia, the Americas, and Oceania. The fixation indexes (F(ST)) for pairwise comparisons between the risk haplotypes for continental populations were calculated for MYH9 haplotypes; F(ST) ranged from 0.27-0.40 for Africa compared to other continental populations, possibly due to selection. Uniquely in Africa, the Yoruba population showed high frequency extended haplotype length around the core risk allele (C) compared to the alternative allele (T) at the same locus (rs4821481, iHs = 2.67), as well as high population differentiation (F(ST(CEU vs. YRI)) = 0.51) in HapMap Phase II data, also observable only in the Yoruba population from HGDP (F(ST) = 0.49), pointing to an instance of recent selection in the genomic region. The population-specific divergence in MYH9 risk allele frequencies among the world's populations may prove important in risk assessment and public health policies to mitigate the burden of kidney disease in vulnerable populations.

摘要

MYH9 最近被鉴定为肾脏易感性基因(OR 3-8,p < 10(-8)),主要影响非洲裔人群的肾脏疾病。风险单倍型(E-1)在非裔美国人中的频率(>或= 60%)远高于欧洲裔美国人(< 4%),这揭示了主要健康差异的遗传基础。MYH9 风险等位基因和 E-1 风险单倍型的人群分布以及作用于 MYH9 区域的人口和选择压力尚未得到充分探索。我们使用 HapMap 二期的可用数据,从跨越内含子 12-23 的 4 个标记单核苷酸多态性(SNP)重建了 MYH9 单倍型,并对人类基因组多样性面板(HGDP)中的 938 个 DNA 进行了基因分型。E-1 风险单倍型呈现出一个渐变,在撒哈拉以南非洲人群中最为常见(范围 50-80%),在中东(9-27%)和欧洲(0-9%)人群中较少见,在亚洲、美洲和大洋洲则罕见或不存在。我们计算了 MYH9 单倍型的大陆人群之间风险单倍型的固定指数(F(ST));非洲与其他大陆人群之间的 F(ST) 范围为 0.27-0.40,这可能是由于选择造成的。在非洲,尤为人注意的是,与同一基因座(rs4821481,iHs = 2.67)的替代等位基因(T)相比,Yoruba 人群中核心风险等位基因(C)周围的扩展单倍型长度频率较高(F(ST(CEU vs. YRI)) = 0.51),这在 HapMap 二期数据中也可以观察到,仅在 HGDP 的 Yoruba 人群中也可以观察到(F(ST) = 0.49),这表明该基因组区域存在近期选择。世界人群中 MYH9 风险等位基因频率的人群特异性差异可能在风险评估和公共卫生政策中证明是重要的,以减轻弱势人群的肾脏疾病负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834b/2901326/46152d249459/pone.0011474.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验